Insiders · Profile

Goodman Noah

Chief Business Officer at Kymera Therapeutics. Filing since 9 Apr 2026. CIK 0002060075

Company

Date

Role

Action

Amount

Of holding

KYMR Kymera Therapeutics, Inc.

1 Jul 2026

Chief Business Officer

Sold on a plan

3,389

$387.33K

6.7%

KYMR Kymera Therapeutics, Inc.

25 Jun 2026

Chief Business Officer

Sold on a plan

5,000

$570.00K

9.1%

KYMR Kymera Therapeutics, Inc.

22 Jun 2026

Chief Business Officer

Sold on a plan

2,500

$247.50K

4.7%

KYMR Kymera Therapeutics, Inc.

14 Apr 2026

Chief Business Officer

Sold on a plan

1,347

$121.23K

2.6%

KYMR Kymera Therapeutics, Inc.

10 Apr 2026

Chief Business Officer

Sold on a plan

2,000

$174.70K

3.7%

KYMR Kymera Therapeutics, Inc.

9 Apr 2026

Chief Business Officer

Sold on a plan

8,264

$723.08K

13.4%

6 decisions on file.